Literature DB >> 11429884

Facile solid-phase synthesis of sulfated tyrosine-containing peptides: total synthesis of human big gastrin-II and cholecystokinin (CCK)-39.

K Kitagawa1, C Aida, H Fujiwara, T Yagami, S Futaki, M Kogire, J Ida, K Inoue.   

Abstract

Chemical synthesis of tyrosine O-sulfated peptides is still a laborious task for peptide chemists because of the intrinsic acid-lability of the sulfate moiety. An efficient cleavage/deprotection procedure without loss of the sulfate is the critical difficulty remaining to be solved for fluoren-9-ylmethoxycarbonyl (Fmoc)-based solid-phase synthesis of sulfated peptides. To overcome the difficulty, TFA-mediated solvolysis rates of a tyrosine O-sulfate [Tyr(SO3H)] residue and two protecting groups, tBu for the hydroxyl group of Ser and 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl (Pbf) for the guanidino group of Arg, were examined in detail. The desulfation obeyed first-order kinetics with a large entropy (59.6 J.K-1.mol-1) and enthalpy (110.5 kJ.mol-1) of activation. These values substantiated that the desulfation rate of the rigidly solvated Tyr(SO3H) residue was strongly temperature-dependent. By contrast, the SN1-type deprotections were less temperature-dependent and proceeded smoothly in TFA of a high ionizing power. Based on the large rate difference between the desulfation and the SN1-type deprotections in cold TFA, an efficient deprotection protocol for the sulfated peptides was developed. Our synthetic strategy for Tyr(SO3H)-containing peptides with this effective deprotection protocol is as follows: (i) a sulfated peptide chain is directly constructed on 2-chlorotrityl resin with Fmoc-based solid-phase chemistry using Fmoc-Tyr(SO3Na)-OH as a building block; (ii) the protected peptide-resin is treated with 90% aqueous TFA at 0 degree C for an appropriate period of time for the cleavage and deprotection. Human cholecystokinin (CCK)-12, mini gastrin-II (14 residues), and little gastrin-II (17 residues) were synthesized with this method in 26-38% yields without any difficulties. This method was further applied to the stepwise synthesis of human big gastrin-II (34 residues), CCK-33 and -39. Despite the prolonged acid treatment (15-18 h at 0 degree C), the ratios of the desulfated peptides were less than 15%, and the pure sulfated peptides were obtained in around 10% yields.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11429884     DOI: 10.1021/jo000895y

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  13 in total

1.  Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival.

Authors:  Jeremy A Lavine; Philipp W Raess; Donald S Stapleton; Mary E Rabaglia; Joshua I Suhonen; Kathryn L Schueler; James E Koltes; John A Dawson; Brian S Yandell; Linda C Samuelson; Margery C Beinfeld; Dawn Belt Davis; Marc K Hellerstein; Mark P Keller; Alan D Attie
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

2.  Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.

Authors:  R De Cristofaro; V De Filippis
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

3.  Sulfotyrosine dipeptide: Synthesis and evaluation as HIV-entry inhibitor.

Authors:  Tong Ju; Duoyi Hu; Shi-Hua Xiang; Jiantao Guo
Journal:  Bioorg Chem       Date:  2016-07-25       Impact factor: 5.275

4.  Chemical Sulfation of Small Molecules - Advances and Challenges.

Authors:  Rami A Al-Horani; Umesh R Desai
Journal:  Tetrahedron       Date:  2010-04-17       Impact factor: 2.457

5.  The phytosulfokine (PSK) receptor is capable of guanylate cyclase activity and enabling cyclic GMP-dependent signaling in plants.

Authors:  Lusisizwe Kwezi; Oziniel Ruzvidzo; Janet I Wheeler; Kershini Govender; Sylvana Iacuone; Philip E Thompson; Chris Gehring; Helen R Irving
Journal:  J Biol Chem       Date:  2011-04-19       Impact factor: 5.157

6.  Solid-phase synthesis of alpha-glucosamine sulfoforms with fragmentation analysis by tandem mass spectrometry.

Authors:  Runhui Liu; Chamnongsak Chanthamontri; Hongling Han; Jesús M Hernández-Torres; Karl V Wood; Scott A McLuckey; Alexander Wei
Journal:  J Org Chem       Date:  2008-07-09       Impact factor: 4.354

7.  Overexpression of pre-pro-cholecystokinin stimulates beta-cell proliferation in mouse and human islets with retention of islet function.

Authors:  Jeremy A Lavine; Philipp W Raess; Dawn Belt Davis; Mary E Rabaglia; Brent K Presley; Mark P Keller; Margery C Beinfeld; Alan S Kopin; Christopher B Newgard; Alan D Attie
Journal:  Mol Endocrinol       Date:  2008-10-09

8.  Template-constrained cyclic sulfopeptide HIV-1 entry inhibitors.

Authors:  Jonathan G Rudick; Meg M Laakso; Ashley C Schloss; William F DeGrado
Journal:  Org Biomol Chem       Date:  2013-11-07       Impact factor: 3.876

9.  Cathepsin L plays a major role in cholecystokinin production in mouse brain cortex and in pituitary AtT-20 cells: protease gene knockout and inhibitor studies.

Authors:  Margery C Beinfeld; Lydiane Funkelstein; Thierry Foulon; Sandrine Cadel; Kouki Kitagawa; Thomas Toneff; Thomas Reinheckel; Christoph Peters; Vivian Hook
Journal:  Peptides       Date:  2009-07-07       Impact factor: 3.750

10.  Regulation of chemokine recognition by site-specific tyrosine sulfation of receptor peptides.

Authors:  Levi S Simpson; John Z Zhu; Theodore S Widlanski; Martin J Stone
Journal:  Chem Biol       Date:  2009-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.